Primary |
Blood Cholesterol Increased |
43.1% |
Hyperlipidaemia |
16.5% |
Hypercholesterolaemia |
8.1% |
Blood Cholesterol |
6.6% |
Hypertension |
3.9% |
Product Used For Unknown Indication |
3.3% |
Blood Pressure Increased |
2.4% |
Drug Use For Unknown Indication |
2.4% |
Dyslipidaemia |
2.4% |
Diabetes Mellitus |
2.1% |
Low Density Lipoprotein Increased |
1.5% |
Blood Triglycerides Increased |
1.2% |
Hypothyroidism |
1.2% |
Mental Disorder |
1.2% |
Coronary Artery Disease |
0.9% |
Pain |
0.9% |
Atrial Fibrillation |
0.6% |
Blood Cholesterol Abnormal |
0.6% |
Cardiac Disorder |
0.6% |
Cerebrovascular Accident Prophylaxis |
0.6% |
|
Rhabdomyolysis |
23.4% |
Myalgia |
19.2% |
Pain In Extremity |
10.2% |
Vision Blurred |
5.4% |
Muscular Weakness |
4.2% |
Pain |
4.2% |
Vomiting |
4.2% |
Amyotrophic Lateral Sclerosis |
3.0% |
Medication Error |
3.0% |
Muscle Spasms |
3.0% |
Drug Interaction |
2.4% |
Neuropathy Peripheral |
2.4% |
Pharmaceutical Product Complaint |
2.4% |
Rash |
2.4% |
Back Pain |
1.8% |
Dyspnoea |
1.8% |
Musculoskeletal Pain |
1.8% |
Myopathy |
1.8% |
Myositis |
1.8% |
Nightmare |
1.8% |
|
Secondary |
Product Used For Unknown Indication |
41.6% |
Blood Cholesterol Increased |
12.8% |
Drug Use For Unknown Indication |
10.0% |
Hypertension |
9.1% |
Hyperlipidaemia |
4.4% |
Mental Disorder |
2.9% |
Diabetes Mellitus |
2.8% |
Blood Cholesterol |
2.5% |
Hypercholesterolaemia |
1.8% |
Type Iia Hyperlipidaemia |
1.4% |
Blood Cholesterol Abnormal |
1.3% |
Hypothyroidism |
1.3% |
Somatoform Disorder |
1.2% |
Arthritis |
1.1% |
Depression |
1.1% |
Pain |
1.1% |
Blood Triglycerides Increased |
0.9% |
Cardiac Disorder |
0.9% |
Gastrooesophageal Reflux Disease |
0.9% |
Neuralgia |
0.9% |
|
Myalgia |
12.9% |
Completed Suicide |
11.9% |
Muscle Spasms |
9.0% |
Rhabdomyolysis |
7.5% |
Poisoning |
6.0% |
Toxicity To Various Agents |
6.0% |
Drug Hypersensitivity |
5.5% |
Tremor |
5.5% |
Urticaria |
4.5% |
Death |
3.5% |
Drug Ineffective |
3.5% |
Liver Function Test Abnormal |
3.5% |
Staphylococcal Sepsis |
3.5% |
Amyotrophic Lateral Sclerosis |
2.5% |
Blood Glucose Increased |
2.5% |
Cardiac Arrest |
2.5% |
Drug Interaction |
2.5% |
Drug Toxicity |
2.5% |
Malaise |
2.5% |
Pain In Extremity |
2.5% |
|
Concomitant |
Product Used For Unknown Indication |
28.9% |
Drug Use For Unknown Indication |
15.5% |
Hypertension |
10.6% |
Blood Cholesterol Increased |
6.4% |
Diabetes Mellitus |
5.0% |
Depression |
3.6% |
Pain |
3.4% |
Rheumatoid Arthritis |
3.0% |
Type 2 Diabetes Mellitus |
2.7% |
Chronic Obstructive Pulmonary Disease |
2.4% |
Atrial Fibrillation |
2.3% |
Gastrooesophageal Reflux Disease |
2.2% |
Osteoporosis |
2.2% |
Anxiety |
2.0% |
Blood Cholesterol |
1.8% |
Prophylaxis |
1.7% |
Smoking Cessation Therapy |
1.6% |
Asthma |
1.6% |
Cardiac Disorder |
1.6% |
Multiple Myeloma |
1.4% |
|
Vomiting |
11.1% |
Weight Decreased |
10.6% |
Weight Increased |
8.2% |
Drug Ineffective |
6.9% |
Nausea |
5.6% |
Flushing |
5.5% |
Pain |
5.5% |
Myocardial Infarction |
4.5% |
Pruritus |
4.5% |
Type 2 Diabetes Mellitus |
4.5% |
Dyspnoea |
4.4% |
Tremor |
4.1% |
Pneumonia |
3.6% |
Rash |
3.4% |
Pain In Extremity |
3.1% |
Death |
3.1% |
Blood Glucose Increased |
3.1% |
Vision Blurred |
3.1% |
Somnolence |
2.7% |
Urinary Tract Infection |
2.7% |
|
Interacting |
Hypertension |
10.5% |
Drug Use For Unknown Indication |
9.6% |
Diabetes Mellitus |
8.8% |
Blood Cholesterol Increased |
7.0% |
Cardiac Disorder |
7.0% |
Hypercholesterolaemia |
7.0% |
Smoking Cessation Therapy |
7.0% |
Nervous System Disorder |
5.3% |
Prostate Cancer |
5.3% |
Wolff-parkinson-white Syndrome |
4.4% |
Chronic Hepatitis |
3.5% |
Dyslipidaemia |
3.5% |
Dyspnoea |
3.5% |
Insomnia |
3.5% |
Renal Failure Chronic |
3.5% |
Thrombocytopenia |
3.5% |
Blood Cholesterol |
1.8% |
Blood Pressure |
1.8% |
Chest Pain |
1.8% |
Gastrointestinal Disorder |
1.8% |
|
Rhabdomyolysis |
33.3% |
Drug Interaction |
13.3% |
Dizziness Postural |
6.7% |
Extrasystoles |
6.7% |
Off Label Use |
6.7% |
Aspartate Aminotransferase Increased |
3.3% |
Cardiac Flutter |
3.3% |
Coma |
3.3% |
Drug Ineffective |
3.3% |
Oedema Mouth |
3.3% |
Swollen Tongue |
3.3% |
Therapeutic Response Decreased |
3.3% |
Tooth Loss |
3.3% |
Urine Colour Abnormal |
3.3% |
Vision Blurred |
3.3% |
|